Early Loop-Diuretic Administration and Subsequent Kidney Deterioration in Hospitalized Patients with Heart Failure: A MIMIC-IV Landmark Study
Early loop diuretics are central to decongestion in heart failure, but their association with subsequent kidney deterioration remains uncertain. We conducted a retrospective 6-hour landmark study of adults with ICD-coded heart failure in MIMIC-IV. Exposure was documented administration of furosemide, bumetanide, or torsemide before 6 hours. Eligible admissions required baseline creatinine and a follow-up measurement from 6 to <48 hours. Kidney deterioration was defined as a creatinine increase of ≥0.3 mg/dL or ≥1.5-fold from baseline. We estimated crude and adjusted associations using propensity-score weighting and augmented inverse probability weighting (AIPW); adjusted and weighted confidence intervals accounted for repeated admissions by patient, whereas the crude interval did not. Among 23,336 admissions from 15,764 patients, 2,453 (10.5%) received early treatment and 4,506 (19.3%) met the endpoint. Kidney deterioration occurred in 22.7% of early-treated admissions versus 18.9% of comparators (crude risk ratio [RR] 1.20, 95% CI 1.11-1.30). The directly adjusted RR was 1.30 (95% CI 1.20-1.41), the overlap-weighted RR was 1.31 (95% CI 1.21-1.43), and the AIPW RR was 1.31 (95% CI 1.20-1.44). The overlap-weighted absolute risk difference was 5.5 percentage points (95% CI 3.7-7.4). Mortality was not significantly associated with early treatment (RR 1.12, 95% CI 0.96-1.30). Restricting the endpoint to the first follow-up creatinine attenuated the association (overlap-weighted RR 1.01, 95% CI 0.87-1.17), highlighting sensitivity to monitoring intensity. Early loop-diuretic administration was associated with higher subsequent creatinine-defined deterioration, but differential surveillance and confounding by indication preclude causal conclusions or recommendations to delay treatment.
Authors
- Batool Mrayyan
- Mustafa Salaho (ORCID: https://orcid.org/0009-0006-4318-071X)
Institutions
- Isra University (JO)
Publication Details
- Journal
- Journal of Cardiovascular Pharmacology
- Published
- 2026-11-17
- DOI
- https://doi.org/10.1097/fjc.0000000000001902
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00